Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 15, 2017. The report serves as a notification regarding the vesting of conditional share awards and the subsequent sale or withholding of shares to meet tax liabilities for Persons Discharging Managerial Responsibility (PDMRs) and persons closely associated with them (PCAs). These transactions relate to awards made in 2014 under the GlaxoSmithKline Share Value Plan (SVP), which vested on February 13, 2017.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details specific equity transactions involving Ordinary Shares and American Depositary Shares (ADSs).
| Transaction Type | Instrument | Volume | Price | Counterparty |
|---|---|---|---|---|
| Vesting | Ordinary Shares | 6,652 | £15.8281 | Mr L Debruyne |
| Vesting | Ordinary Shares | 10,050 | £15.8281 | Mrs V A Whyte |
| Sale for Tax | Ordinary Shares | 4,725 | £15.8281 | Mrs V A Whyte |
| Vesting | ADSs | 2,300 | $40.28 | Dr K Slaoui (PCA) |
Note: For Dr K Slaoui, 822 ADSs were withheld to meet tax liabilities as part of the 2,300 ADSs vested.
Material Changes
The filing does not report material changes to the company's financial position, operations, or strategy compared to prior periods. The document strictly reports the execution of pre-existing equity compensation plans.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. The transactions described are routine administrative actions related to employee compensation vesting and tax compliance.
Investor Verification Points
- Confirm the total number of shares vested and sold by PDMRs and PCAs on February 13, 2017.
- Verify the transaction prices (£15.8281 for Ordinary Shares and $40.28 for ADSs) against market prices on the transaction date.
- Ensure the distinction between shares vested, shares sold for tax, and shares withheld for tax is accurately reflected in internal records.